Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
06 Jun 2022
Historique:
received: 21 02 2022
accepted: 04 05 2022
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 9 6 2022
Statut: epublish

Résumé

The optimal management for peritoneal dissemination in patients with hepatocellular carcinoma remains unclear. Although several reports have described the usefulness of surgical resection, the indications should be carefully considered. Herein, we report the case of a patient with hepatocellular carcinoma with peritoneal recurrence who underwent surgical resection using an indocyanine green fluorescence navigation system and achieved favorable disease control. A 45-year-old Asian woman underwent left hemihepatectomy for a ruptured hepatocellular carcinoma. Seventeen months after the initial surgery, a single nodule near the cut surface of the liver was detected on computed tomography, along with elevation of tumor markers. The patient was diagnosed with peritoneal metastasis and underwent a surgical resection. Twelve months later, a single nodule on the dorsal side of the right hepatic lobe was detected on computed tomography, and we performed surgical resection. Indocyanine green (0.5 mg/kg) was intravenously administered 3 days before surgery, and the indocyanine green fluorescence imaging system revealed clear green fluorescence in the tumor, which helped us perform complete resection. Indocyanine green fluorescence enabled the detection of additional lesions that could not be identified by preoperative imaging, especially in the second metastasectomy. There was no further recurrence at 3 months postoperatively. When considering surgical intervention for peritoneal recurrence in patients with hepatocellular carcinoma, complete resection is mandatory. Given that disseminated nodules are sometimes too small to be detected by preoperative imaging studies, intraoperative indocyanine green fluorescence may be an essential tool for determining the indications for surgical resection.

Sections du résumé

BACKGROUND BACKGROUND
The optimal management for peritoneal dissemination in patients with hepatocellular carcinoma remains unclear. Although several reports have described the usefulness of surgical resection, the indications should be carefully considered. Herein, we report the case of a patient with hepatocellular carcinoma with peritoneal recurrence who underwent surgical resection using an indocyanine green fluorescence navigation system and achieved favorable disease control.
CASE PRESENTATION METHODS
A 45-year-old Asian woman underwent left hemihepatectomy for a ruptured hepatocellular carcinoma. Seventeen months after the initial surgery, a single nodule near the cut surface of the liver was detected on computed tomography, along with elevation of tumor markers. The patient was diagnosed with peritoneal metastasis and underwent a surgical resection. Twelve months later, a single nodule on the dorsal side of the right hepatic lobe was detected on computed tomography, and we performed surgical resection. Indocyanine green (0.5 mg/kg) was intravenously administered 3 days before surgery, and the indocyanine green fluorescence imaging system revealed clear green fluorescence in the tumor, which helped us perform complete resection. Indocyanine green fluorescence enabled the detection of additional lesions that could not be identified by preoperative imaging, especially in the second metastasectomy. There was no further recurrence at 3 months postoperatively.
CONCLUSION CONCLUSIONS
When considering surgical intervention for peritoneal recurrence in patients with hepatocellular carcinoma, complete resection is mandatory. Given that disseminated nodules are sometimes too small to be detected by preoperative imaging studies, intraoperative indocyanine green fluorescence may be an essential tool for determining the indications for surgical resection.

Identifiants

pubmed: 35659738
doi: 10.1186/s13256-022-03440-5
pii: 10.1186/s13256-022-03440-5
pmc: PMC9169282
doi:

Substances chimiques

Indocyanine Green IX6J1063HV

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

222

Informations de copyright

© 2022. The Author(s).

Références

BMC Surg. 2021 Mar 2;21(1):107
pubmed: 33653302
J Gastroenterol. 2013 Oct;48(10):1136-43
pubmed: 23179608
Asian J Endosc Surg. 2015 Nov;8(4):465-7
pubmed: 26708587
World J Surg Oncol. 2014 Sep 25;12:298
pubmed: 25255984
Korean J Intern Med. 2017 Sep;32(5):943-944
pubmed: 27608971
World J Gastroenterol. 2008 Jun 28;14(24):3927-31
pubmed: 18609723
Int J Clin Oncol. 2013 Apr;18(2):232-41
pubmed: 22200990
Hepatol Res. 2022 Jan;52(1):5-66
pubmed: 34050584
Ann Thorac Cardiovasc Surg. 2016 Dec 20;22(6):367-369
pubmed: 27193496
Surg Case Rep. 2018 Nov 7;4(1):130
pubmed: 30406329
Surgery. 2013 May;153(5):727-31
pubmed: 22705249
Surg Case Rep. 2018 Jul 13;4(1):76
pubmed: 30003446
Cancer. 2009 Jun 1;115(11):2491-504
pubmed: 19326450
Mol Clin Oncol. 2021 Dec;15(6):259
pubmed: 34754446
Dig Dis. 2015 Oct;33(6):765-70
pubmed: 26488173
Photodiagnosis Photodyn Ther. 2019 Mar;25:417-420
pubmed: 30708088
J Hepatobiliary Pancreat Sci. 2020 Oct;27(10):673-681
pubmed: 32602193
Innov Surg Sci. 2021 Apr 22;6(2):59-66
pubmed: 34589573
Int J Surg Case Rep. 2018;46:56-61
pubmed: 29684806
J Gastroenterol. 2002;37(7):571-4
pubmed: 12162418

Auteurs

Yuma Tani (Y)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Hiroki Sato (H)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. h.sato10220309@gmail.com.

Ryuichi Yoshida (R)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Kazuya Yasui (K)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Yuzo Umeda (Y)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Kazuhiro Yoshida (K)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Tomokazu Fuji (T)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Kenjiro Kumano (K)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Kosei Takagi (K)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Masaaki Kagoura (M)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Takahito Yagi (T)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Toshiyoshi Fujiwara (T)

Department of Gastroenterological Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH